期刊文献+

双心房输注在并发肺动脉高压的复杂性先天性心脏病患儿手术中的应用评价

Effects of biatrial infusion on intraoperative hemodynamics after cardiopulmonary bypass in patients undergoing correction of complex congenital heart disease
下载PDF
导出
摘要 目的:评估双心房输注对并发肺动脉高压的复杂性先天性心脏病患儿(复杂先心病)术后血流动力学的影响。方法:择期行复杂先心病矫治术的患儿46例,年龄6月一5岁,体质量5~19kg,心功能分级Ⅱ或Ⅲ级,随机分为两组(每组n=23):双心房输注组(经左房泵入具有血管收缩作用的正性肌力药,从右房或肺动脉泵入血管扩张药物)和右心房输注组(直接经右房泵入具有血管收缩作用的正性肌力药和血管扩张药物)。腔静脉开放后常规给予血管活性药物,双心房输注组经中心静脉输注米力农0.5~0.75μg/(kg·min),经左心房输注多巴胺5~lOμg/(kg·min)、肾上腺素0.03~0.1μg/(kg·min)。右心房输注组经中心静脉输注米力农0.5-0.75μg/(kg·rain)、多巴胺5-10μg/(kg·min)、肾上腺素0.03~0.1μg/(kg·min)。分别于给药前5min(TO)、给药后5min(T1)、10min(T2)、30rain(耶)和60min(T4)时记录平均动脉压(MAP)、HR、平均肺动脉压(MPAP)、左心房压(LAP)、中心静脉压(CVP)和心排出量(CO),计算肺血管阻力指数(PVRI)、体循环血管阻力指数(SVRI)和心指数(cI)。结果:与11D时比较,双心房输注组T1一T4时MAP、CI和SVRI升高,HR、MPAP、T|AP、CVP和PVRI降低(均P〈0.05);右心房输注组T1~T4时MAP、MPAP、LAP和PVRI降低,cI升高(均P〈0.05),HR、CVP和SVRI差异无统计学意义。与右心房输注组比较,双心房输注组MAP、CI和SVRI升高,HR、MPAP、LAP、PVRI和CVP降低(均P〈0.05)。结论:双心房输注可改善复杂先心病患者矫治术后左心排血功能,降低肺动脉压和肺循环血管阻力。 AIM: To investigate the effects of biatrial infusion on the intraoperative hemodynamics after cardiopulmonary bypass (CPB) in patients undergoing correction of complex congenital heart disease complicated by pulmonary hypertension (PH). METHODS: Forty-six NYHA class II or Ill patients (aged 6 months to 5 years and weighing 5 - 19 kg) undergoing corrective surgery for complex congenital heart disease complicated by PH were randomly divided into two groups ( n -- 23 each). Group I was the double atrial infusion group in which drugs with vasoconstrictive and positive inotropic effect were pumped via the left atrium and drugs with vasodilative effect were pumped via the right atrium or pulmonary artery. Group II was the right atrial infusion group in which vasoconstrictive and positive inotropic drugs and vasodilative drugs were pumped directly via the right atrium. MAP, HR, MPAP, PCWP, CVP and CO were recorded 5 rain before drug administration (T0) as well as 5, 10, 30 and 60 rain after drug administration (T1 -4 ). Pulmonary vascular resistance index (PVRI), systemic vascular resistance index (SVRI) and CI were also calculated. RESULTS: Compared with those at TO, MAP, MPAP, PCWP and PVRI significantly decreased, whereas CI increased at T1 -4 in group II and MAP, CI and SVRI significantly increased. HR, MPAP, PCWP, CVP and PVRI decreased at T1 -4 in group II (P 〈 0.05). Compared with those in group II, MAP, CI and SVRI were significantly higher and HR, MPAP, PCWP, PVRI and CVP were lower (P 〈 0. 05 ). CONCLUSION: Biatrial infusion can effectively reduce PAP and PVRI and increase CI after CPB during correction of complex congenital heart disease complicated by PH.
出处 《心脏杂志》 CAS 2013年第5期582-585,共4页 Chinese Heart Journal
关键词 心脏病 先天性 复杂性 双心房输注 肺动脉压 congenital heart disease complex pulmonary hypertension cardiopulmonary bypass biatrial infusion
  • 相关文献

参考文献5

  • 1姚永兴,姜桢,李冰冰,曾真.肺、体循环分别给药治疗体外循环后肺动脉高压危象的临床分析[J].中华医学杂志,2008,88(5):323-325. 被引量:4
  • 2Tritapepe L,Voci P,Cagliati AA,et al.Successful weaning from cardiopulmonary bypass with central veous prostaglandin El and left atrial norepinephrine infusion in patients with acute pulmonary hypertention[J].Crit Care Med,1999,27(10):2180-2183.
  • 3徐志伟.小儿心脏外科学[M].北京:人民军医出版社,2006:38.
  • 4Cau SB,DiasJunior CA, Montenegro MF,et al.Dosedependent beneficial hemodynamic effects of BAY 4 12272 in a canine model of acute pulmonary thromboembolism[J].Eur J Pharmacol,2008,581(1-2):132-137.
  • 5DiasJunior CA,Gladwin MT,TanusSantos JE. Lowdose intravenous nitrite improves hemodynamies in a canine model of acute pulmonary thromboembolism[J].Free Radic Biol Med,2006,41(12):1764-1770.

二级参考文献9

  • 1姚永兴,姜桢.肺-体循环分别给药救治体外循环停机困难一例[J].中华医学杂志,2006,86(41):2947-2949. 被引量:1
  • 2Hopkins RA, Bull C, Haworth SG, et al. Pulmonary hypertensive crises following surgery for congenital heart defects in young children. Eur J Cardiothorac Surg, 1991, 5:628-634.
  • 3Reich DL, Bodian CA, Krol M, et al. Intraoperative hemodynamic predictors of mortality, stroke, and myocardial infarction after coronary artery bypass surgery. Anesth Analg, 1999, 89:814-822.
  • 4Tritapepe L, Voci P, Cogliati AA, et al. Successful weaning from cardiopuhnonary bypass with central venous prostaglandin El and left atrial norepinephrine infusion in patients with acute pulmonary hypertension. Crit Care Med, 1999, 27:2180-2183.
  • 5Fischer LG, Van Aken H, Burkle H. Management of pulmonary hypertension: physiological and pharmacological considerations for anesthesiologists. Anesth Analg, 2003, 96: 1603-1616.
  • 6Aral A, Oguz M, Ozberrak H, et al. Hemodynamic advantages of left atrial epinephrine administration in open heart operations. Ann Thorac Surg, 1997, 64:1046-1049.
  • 7Aranda M, Bradford KK, Pearl RG. Combined therapy with inhaled nitric oxide and intravenous vasodilators during acute and chronic experimental puhnonary hypertension. Anesth Analg, 1999. 89,152-158.
  • 8D' Ambra MN, Laraia PJ, Philbin DM, et al. Prostaglandin E1 : a new therapy for refractory right heart failure and pulmonary hypertension after mitral valve replacement. J Thorac Cardiovasc Surg, 1985, 89:567-572.
  • 9王天龙.吸入性一氧化氮的临床应用指征[J].中华医学杂志,2004,84(6):524-528. 被引量:4

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部